AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
MULTICENTER COMPARISON OF BACTEC-9050 AND BACTEC-9240 BLOOD CULTURE SYSTEMS
Authors: MURRAY PR HOLLICK GE JERRIS RC WILSON ML
Citation: Pr. Murray et al., MULTICENTER COMPARISON OF BACTEC-9050 AND BACTEC-9240 BLOOD CULTURE SYSTEMS, Journal of clinical microbiology, 36(6), 1998, pp. 1601-1603
USE OF MOLECULAR AND REFERENCE SUSCEPTIBILITY TESTING METHODS IN A MULTICENTER EVALUATION OF MICROSCAN DRIED OVERNIGHT GRAM-POSITIVE MIC PANELS FOR DETECTION OF VANCOMYCIN AND HIGH-LEVEL AMINOGLYCOSIDE RESISTANCES IN ENTEROCOCCI
Authors: CHEN YS MARSHALL SA WINOKUR PL COFFMAN SL WILKE WW MURRAY PR SPIEGEL CA PFALLER MA DOERN GV JONES RN
Citation: Ys. Chen et al., USE OF MOLECULAR AND REFERENCE SUSCEPTIBILITY TESTING METHODS IN A MULTICENTER EVALUATION OF MICROSCAN DRIED OVERNIGHT GRAM-POSITIVE MIC PANELS FOR DETECTION OF VANCOMYCIN AND HIGH-LEVEL AMINOGLYCOSIDE RESISTANCES IN ENTEROCOCCI, Journal of clinical microbiology, 36(10), 1998, pp. 2996-3001
CONTROLLED CLINICAL LABORATORY COMPARISON OF BACTEC PLUS AEROBIC F RESIN MEDIUM WITH BACT/ALERT AEROBIC FAN MEDIUM FOR DETECTION OF BACTEREMIA AND FUNGEMIA/
Authors: JORGENSEN JH MIRRETT S MCDONALD LC MURRAY PR WEINSTEIN MP FUNE J TRIPPY CW MASTERSON M RELLER LB
Citation: Jh. Jorgensen et al., CONTROLLED CLINICAL LABORATORY COMPARISON OF BACTEC PLUS AEROBIC F RESIN MEDIUM WITH BACT/ALERT AEROBIC FAN MEDIUM FOR DETECTION OF BACTEREMIA AND FUNGEMIA/, Journal of clinical microbiology, 35(1), 1997, pp. 53-58
MICROBIAL-GROWTH INSIDE SALINE-FILLED BREAST IMPLANTS
Authors: YOUNG VL HERTL MC MURRAY PR JENSEN J WITT H SCHORR MW
Citation: Vl. Young et al., MICROBIAL-GROWTH INSIDE SALINE-FILLED BREAST IMPLANTS, Plastic and reconstructive surgery, 100(1), 1997, pp. 182-196
TENTATIVE INTERPRETIVE CRITERIA AND QUALITY-CONTROL PARAMETERS FOR IN-VITRO SUSCEPTIBILITY TESTING OF NEISSERIA-GONORRHOEAE TO 2 FLUOROQUINOLONES (PD-131628 AND GREPAFLOXACIN (OPC-17116))
Authors: SEWELL DL BARRY AL ALLEN SD FUCHS PC MURRAY PR TENOVER FC
Citation: Dl. Sewell et al., TENTATIVE INTERPRETIVE CRITERIA AND QUALITY-CONTROL PARAMETERS FOR IN-VITRO SUSCEPTIBILITY TESTING OF NEISSERIA-GONORRHOEAE TO 2 FLUOROQUINOLONES (PD-131628 AND GREPAFLOXACIN (OPC-17116)), Journal of antimicrobial chemotherapy, 37(1), 1996, pp. 139-143
COMPARISON OF SPIRAL GRADIENT END-POINT AND AGAR DILUTION METHODS FORSUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA - A MULTILABORATORY COLLABORATIVE EVALUATION (VOL 34, PG 174, 1996)
Authors: WEXLER HM MOLITORIS E MURRAY PR WASHINGTON J ZABRANSKY RJ EDELSTEIN PH FINEGOLD SM
Citation: Hm. Wexler et al., COMPARISON OF SPIRAL GRADIENT END-POINT AND AGAR DILUTION METHODS FORSUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA - A MULTILABORATORY COLLABORATIVE EVALUATION (VOL 34, PG 174, 1996), Journal of clinical microbiology, 34(9), 1996, pp. 2341-2341
CONTEMPORARY TESTING FOR ENTERIC PATHOGENS - THE POTENTIAL FOR COST, TIME, AND HEALTH-CARE SAVINGS
Authors: MORRIS AJ MURRAY PR RELLER LB
Citation: Aj. Morris et al., CONTEMPORARY TESTING FOR ENTERIC PATHOGENS - THE POTENTIAL FOR COST, TIME, AND HEALTH-CARE SAVINGS, Journal of clinical microbiology, 34(7), 1996, pp. 1776-1778
DEVELOPMENT OF INTERPRETIVE CRITERIA AND QUALITY-CONTROL LIMITS FOR MACROLIDE AND CLINDAMYCIN SUSCEPTIBILITY TESTING OF STREPTOCOCCUS-PNEUMONIAE
Authors: JORGENSEN JH SWENSON JM TENOVER FC BARRY A FERRARO MJ MURRAY PR RELLER LB
Citation: Jh. Jorgensen et al., DEVELOPMENT OF INTERPRETIVE CRITERIA AND QUALITY-CONTROL LIMITS FOR MACROLIDE AND CLINDAMYCIN SUSCEPTIBILITY TESTING OF STREPTOCOCCUS-PNEUMONIAE, Journal of clinical microbiology, 34(11), 1996, pp. 2679-2684
COMPARISON OF SPIRAL GRADIENT END-POINT AND AGAR DILUTION METHODS FORSUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA - A MULTILABORATORY COLLABORATIVE EVALUATION
Authors: WEXLER HM MOLITORIS E MURRAY PR WASHINGTON J ZABRANSKY RJ EDELSTEIN PH FINEGOLD SM
Citation: Hm. Wexler et al., COMPARISON OF SPIRAL GRADIENT END-POINT AND AGAR DILUTION METHODS FORSUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA - A MULTILABORATORY COLLABORATIVE EVALUATION, Journal of clinical microbiology, 34(1), 1996, pp. 170-174
EMERGING MULTIPLY RESISTANT ENTEROCOCCI AMONG CLINICAL ISOLATES .1. PREVALENCE DATA FROM 97 MEDICAL-CENTER SURVEILLANCE STUDY IN THE UNITED-STATES
Authors: JONES RN SADER HS ERWIN ME ANDERSON SC ALDRIDGE KA ALLEN S ANHALT J APPELBAUM P ARRINGTON KL AYERS L BAKER C BEAVIS K BERGER J BERTHOLD G BIRNBAUM M BOYLE J BRECHER S BRECKENRIDGE R BROWN W BRUCKNER D CARROLL K CHAUDHARY S CLEARY T COCKERILL F COYLE M CRAWFORD V DALTON H DOERN G EDBERG S GELFAND M GERLACH EH GOODMAN N GORZYNSKI E GREEN P GROSCHEL D HANFF P HANNA B HARRELL L HAUGEN T HEAGREY M HUMPHRIES J ISENBERG H JENKINS S JONES E JORGENSEN J KAUFFMAN C KEISER J KOCKA F KOMINOS S LEVISON M LOCKWOOD W MANOS J MARTIN W MCLAUGHLIN J METCHOCK B MICKELSEN P MOODY J MORELLO J MOSTOW S MOTYL M MURRAY B MURRAY PR NOLTE F PARK C PEZZLO M PRICE M PUSCSH A REED K REIMER L RINALDI M RISTUCCIA A ROBINSON A ROSATI L SAUBOLLE M SCHALHAB J SCHULTZ G SCHWALBE R SEWELL D SHALES D SIERRA M SINNOTT J SLIFKIN M SMITH L SPIEGEL C STANECK J STEELEMOORE L STEIN G STEVENS D STRATTON C TAN J THOMAS J WAITES K WEINSTEIN M WELCH W WIN W WOODS G WRIGHT L YUNGBLUTH M ZWADYK P
Citation: Rn. Jones et al., EMERGING MULTIPLY RESISTANT ENTEROCOCCI AMONG CLINICAL ISOLATES .1. PREVALENCE DATA FROM 97 MEDICAL-CENTER SURVEILLANCE STUDY IN THE UNITED-STATES, Diagnostic microbiology and infectious disease, 21(2), 1995, pp. 85-93
TESTS FOR SUSCEPTIBILITY OF STREPTOCOCCUS-PNEUMONIAE TO CEFDINIR - PROPOSED INTERPRETIVE CRITERIA AND QUALITY-CONTROL PARAMETERS FOR BROTH MICRODILUTION AND DISC DIFFUSION METHODS
Authors: FUCHS PC BARRY AL TENOVER FC ALLEN SD JORGENSEN JH MURRAY PR
Citation: Pc. Fuchs et al., TESTS FOR SUSCEPTIBILITY OF STREPTOCOCCUS-PNEUMONIAE TO CEFDINIR - PROPOSED INTERPRETIVE CRITERIA AND QUALITY-CONTROL PARAMETERS FOR BROTH MICRODILUTION AND DISC DIFFUSION METHODS, Journal of antimicrobial chemotherapy, 36(5), 1995, pp. 781-786
PAECILOMYCES-VARIOTII CONTAMINATION IN THE LUMEN OF A SALINE-FILLED BREAST IMPLANT
Authors: YOUNG VL HERTL MC MURRAY PR LAMBROS VS
Citation: Vl. Young et al., PAECILOMYCES-VARIOTII CONTAMINATION IN THE LUMEN OF A SALINE-FILLED BREAST IMPLANT, Plastic and reconstructive surgery, 96(6), 1995, pp. 1430-1434
UPDATE OF LOMEFLOXACIN IN-VITRO ACTIVITY AND SPECTRUM - A MULTICENTERTRIAL TESTING CONTEMPORARY PATHOGENS FOLLOWING FOOD-AND-DRUG-ADMINISTRATION VALIDATION GUIDELINES
Authors: JONES RN SADER HS ERWIN ME ALDRIDGE K DOERN GV HINDLER J FRITSCHE TR MURRAY PR SEWELL D STEIN G WASHINGTON JA
Citation: Rn. Jones et al., UPDATE OF LOMEFLOXACIN IN-VITRO ACTIVITY AND SPECTRUM - A MULTICENTERTRIAL TESTING CONTEMPORARY PATHOGENS FOLLOWING FOOD-AND-DRUG-ADMINISTRATION VALIDATION GUIDELINES, Diagnostic microbiology and infectious disease, 20(2), 1994, pp. 93-98
MULTICENTER EVALUATION OF THE IN-VITRO ACTIVITY OF PIPERACILLIN-TAZOBACTAM COMPARED WITH 11 SELECTED BETA-LACTAM ANTIBIOTICS AND CIPROFLOXACIN AGAINST MORE THAN 42,000 AEROBIC GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA
Authors: MURRAY PR CANTRELL HF LANKFORD RB
Citation: Pr. Murray et al., MULTICENTER EVALUATION OF THE IN-VITRO ACTIVITY OF PIPERACILLIN-TAZOBACTAM COMPARED WITH 11 SELECTED BETA-LACTAM ANTIBIOTICS AND CIPROFLOXACIN AGAINST MORE THAN 42,000 AEROBIC GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA, Diagnostic microbiology and infectious disease, 19(2), 1994, pp. 111-120
MINIMUM INHIBITORY CONCENTRATION QUALITY-CONTROL GUIDELINES FOR BIAPENEM, DU-6859A, FK-037, LEVOFLOXACIN, GREPAFLOXACIN, AND CEFTIZOXIME WHEN USING VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TEST METHODS
Authors: BALE MJ JONES RN ERWIN ME MURRAY PR WASHINGTON JA GERLACH EH THORNSBERRY C HINDLER J DOERN GV
Citation: Mj. Bale et al., MINIMUM INHIBITORY CONCENTRATION QUALITY-CONTROL GUIDELINES FOR BIAPENEM, DU-6859A, FK-037, LEVOFLOXACIN, GREPAFLOXACIN, AND CEFTIZOXIME WHEN USING VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TEST METHODS, Diagnostic microbiology and infectious disease, 19(1), 1994, pp. 65-68
NORTH-AMERICAN (UNITED-STATES AND CANADA) COMPARATIVE SUSCEPTIBILITY OF 2 FLUOROQUINOLONES - OFLOXACIN AND CIPROFLOXACIN - A 53-MEDICAL-CENTER SAMPLE OF SPECTRA OF ACTIVITY
Authors: JONES RN HOBAN DJ ALDRIDGE KA ARRINGTON KL BERTHOLD G BRECHER S CLEARY T COYLE M DAVIS J GARAGUSI V GOODMAN NL GORZYNSKI E HANFF P HANNA B ISENBERG HD MCGOWAN J MARTIN WJ MOODY J MURRAY PR RELLER LB RINALDI MG ROSATI LA RYPKA E SAHM D SLIFKIN M SEWELL D SPIEGEL C STECKELBERG JM STEELEMOORE L STEIN G STRATTON C STROZEWSKI K WEINSTEIN M WELCH B WHITE RL WINN W ALFA M NUNS G BLONDEAU J BOURGAULT AM BRUNTON J CLARKE AM FORWARD K GREGSON DB HORSMAN GB JESSAMINE P KIBSEY P KUHN M LAVERDIERE M LOW DE NOBLE MA RENNIE R SMITH JA
Citation: Rn. Jones et al., NORTH-AMERICAN (UNITED-STATES AND CANADA) COMPARATIVE SUSCEPTIBILITY OF 2 FLUOROQUINOLONES - OFLOXACIN AND CIPROFLOXACIN - A 53-MEDICAL-CENTER SAMPLE OF SPECTRA OF ACTIVITY, Diagnostic microbiology and infectious disease, 18(1), 1994, pp. 49-56
LABORATORY DETECTION OF ANAEROBIC BACTEREMIA
Authors: RYAN MR MURRAY PR
Citation: Mr. Ryan et Pr. Murray, LABORATORY DETECTION OF ANAEROBIC BACTEREMIA, Clinics in laboratory medicine, 14(1), 1994, pp. 107-117
PREVALENCE OF CORYNEBACTERIUM-UREALYTICUM IN URINE SPECIMENS COLLECTED AT A UNIVERSITY-AFFILIATED MEDICAL-CENTER
Authors: RYAN M MURRAY PR
Citation: M. Ryan et Pr. Murray, PREVALENCE OF CORYNEBACTERIUM-UREALYTICUM IN URINE SPECIMENS COLLECTED AT A UNIVERSITY-AFFILIATED MEDICAL-CENTER, Journal of clinical microbiology, 32(5), 1994, pp. 1395-1396
DEVELOPMENT OF INTERPRETIVE CRITERIA AND QUALITY-CONTROL LIMITS FOR BROTH MICRODILUTION AND DISK DIFFUSION ANTIMICROBIAL SUSCEPTIBILITY TESTING OF STREPTOCOCCUS-PNEUMONIAE
Authors: JORGENSEN JH SWENSON JM TENOVER FC FERRARO MJ HINDLER JA MURRAY PR
Citation: Jh. Jorgensen et al., DEVELOPMENT OF INTERPRETIVE CRITERIA AND QUALITY-CONTROL LIMITS FOR BROTH MICRODILUTION AND DISK DIFFUSION ANTIMICROBIAL SUSCEPTIBILITY TESTING OF STREPTOCOCCUS-PNEUMONIAE, Journal of clinical microbiology, 32(10), 1994, pp. 2448-2459
IN-VITRO COMPARISON ACTIVITY OF OPC-17116, A NEW FLUOROQUINOLONE, AGAINST MORE THAN 5,000 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS
Authors: SADER HS JONES RN ALLEN SD GERLACH EH MURRAY PR WASHINGTON JA
Citation: Hs. Sader et al., IN-VITRO COMPARISON ACTIVITY OF OPC-17116, A NEW FLUOROQUINOLONE, AGAINST MORE THAN 5,000 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS, Journal of chemotherapy, 5(5), 1993, pp. 283-288
IN-VITRO COMPARISON OF E4868, A NEW TRIFLUOROQUINOLONE, WITH CIPROFLOXACIN AND TEMAFLOXACIN TESTED AGAINST 5192 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS
Authors: MURRAY PR JONES RN WASHINGTON JA GERLACH EH ALLEN SD
Citation: Pr. Murray et al., IN-VITRO COMPARISON OF E4868, A NEW TRIFLUOROQUINOLONE, WITH CIPROFLOXACIN AND TEMAFLOXACIN TESTED AGAINST 5192 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS, Diagnostic microbiology and infectious disease, 17(4), 1993, pp. 307-311
IN-VITRO ACTIVITY OF CEFPODOXIME COMPARED WITH OTHER ORAL CEPHALOSPORINS TESTED AGAINST 5556 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS
Authors: SADER HS JONES RN WASHINGTON JA MURRAY PR GERLACH EH ALLEN SD ERWIN ME
Citation: Hs. Sader et al., IN-VITRO ACTIVITY OF CEFPODOXIME COMPARED WITH OTHER ORAL CEPHALOSPORINS TESTED AGAINST 5556 RECENT CLINICAL ISOLATES FROM 5 MEDICAL-CENTERS, Diagnostic microbiology and infectious disease, 17(2), 1993, pp. 143-150
IN-VITRO ACTIVITY OF CEFTRIAXONE AND OTHER CEPHALOSPORINS AGAINST 602CLINICAL ISOLATES OF STAPHYLOCOCCI FROM GEOGRAPHICALLY DIVERSE MEDICAL-CENTERS
Authors: PFALLER MA BARRY AL SABATH LD KREISWIRTH BN MURRAY PR FUCHS PC MCLAUGHLIN JC
Citation: Ma. Pfaller et al., IN-VITRO ACTIVITY OF CEFTRIAXONE AND OTHER CEPHALOSPORINS AGAINST 602CLINICAL ISOLATES OF STAPHYLOCOCCI FROM GEOGRAPHICALLY DIVERSE MEDICAL-CENTERS, European journal of epidemiology, 9(6), 1993, pp. 658-662
IN-VITRO COMPARISON OF DU-6859A, A NOVEL FLUOROQUINOLONE, WITH OTHER QUINOLONES AND OPAL CEPHALOSPORINS TESTED AGAINST 5086 RECENT CLINICALISOLATES
Authors: MARSHALL SA JONES RN MURRAY PR WASHINGTON JA ALLEN SD GERLACH EH ERWIN ME
Citation: Sa. Marshall et al., IN-VITRO COMPARISON OF DU-6859A, A NOVEL FLUOROQUINOLONE, WITH OTHER QUINOLONES AND OPAL CEPHALOSPORINS TESTED AGAINST 5086 RECENT CLINICALISOLATES, Journal of antimicrobial chemotherapy, 32(6), 1993, pp. 877-884
TENTATIVE CRITERIA FOR CONFIRMING THE IN-VITRO SUSCEPTIBILITIES OF HAEMOPHILUS-INFLUENZAE AND NEISSERIA-GONORRHOEAE TO 2 FLUOROQUINOLONES (SPARFLOXACIN AND LEVOFLOXACIN), INCLUDING QUALITY-CONTROL PARAMETERS
Authors: BARRY AL FUCHS PC ALLEN SD JORGENSEN JH TENOVER FC MURRAY PR HARDY DJ BAKER CN
Citation: Al. Barry et al., TENTATIVE CRITERIA FOR CONFIRMING THE IN-VITRO SUSCEPTIBILITIES OF HAEMOPHILUS-INFLUENZAE AND NEISSERIA-GONORRHOEAE TO 2 FLUOROQUINOLONES (SPARFLOXACIN AND LEVOFLOXACIN), INCLUDING QUALITY-CONTROL PARAMETERS, Journal of clinical microbiology, 31(9), 1993, pp. 2375-2380
Risultati: 1-25 | 26-28